2020 Entire Conference - CH a la carte

Aug 29, 2020 ‐ Aug 31, 2020


After content is purchased, CH is available for: $15 per session

CH expire on 8/31/2022.

Members: $199.00
Standard: $274.00

Products

General Session - Evolving Management Approaches to Anemia in Chronic Kidney Disease: Implications for the Nephrology Nurse (Sponsored by AstraZeneca Pharmaceuticals LP)

Preview Available

General Session - Evolving Management Approaches to Anemia in Chronic Kidney Disease: Implications for the Nephrology Nurse (Sponsored by AstraZeneca Pharmaceuticals LP)

Aug 30, 2020 9:00am ‐ Aug 30, 2020 10:15am

The CE Evaluation process for this event takes place external to ANNA's Online Library.  Click here to access.


Activity Description

Anemia is a common condition in patients with chronic kidney disease (CKD), and its treatment is often challenging because of concerns regarding the safety of current agents; nonresponsiveness to agents; lack of consensus regarding treatment targets; controversy regarding balance between a patient-centric approach versus the use of one-size-fits-all algorithms; and suboptimal coordination between members of the healthcare team managing the anemia.

Although erythropoietic stimulating agents (ESAs) replace deficient native erythropoietin (EPO) in patients with CKD, ESAs do not address iron absorption and mobilization defects that frequently occur in patients with CKD that may blunt the effectiveness of ESA therapy. Stabilization of hypoxia-inducible factor (HIF) via prolyl hydroxylase (PH) domain inhibition represents a potentially promising new therapeutic approach to treat anemia secondary to CKD. Activation of HIF orchestrates a coordinated response to promote erythropoiesis through the stimulation of endogenous EPO production, increased uptake of iron, and mobilization of iron stores. Indeed, several HIF-PH inhibitors are currently in development for the treatment of anemia in CKD, and available clinical trial data suggest that HIF-PH inhibitors offer a number of advantages over ESAs.

In this PeerView Live web broadcast, our panel of experts will offer insight into best practices regarding the treatment of CKD-associated anemia and emphasize that the success of employing current (and future) treatments falls on the members of the interdisciplinary nephrology care team. Foundational guidance will be combined with a discussion of real cases to further highlight new developments in the management of anemia associated with CKD and provide practical guidance on the integration of such advances.

Target Audience

This activity has been designed to meet the educational needs of nephrologists, nephrology nurses, internal medicine physicians, family medicine physicians, and other clinicians involved in the management of chronic kidney disease.

Educational Objectives

Upon completion of this activity, participants will be able to:

    • Describe the prevalence, clinical impact, and pathogenesis of anemia in CKD
    • Identify benefits and limitations associated with current management approaches to anemia in CKD
    • Recognize the mechanism of action of emerging hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors in the management of anemia in CKD
    • Assess safety and efficacy data supporting HIF-PH inhibitor use in patients with anemia in CKD
    • Employ strategies to treat anemia in CKD in accordance with current evidence, expert recommendations, and individual patient needs

Providership, Credit, and Support


This CME/MOC/CNE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP in collaboration with FibroGen.

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points and patient safety MOC Credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared with ABIM through the ACCME’s Program and Activity Reporting System (PARS). Blinded individual or aggregated participant data may be shared with the funder of the activity.

Continuing Nursing Education

Medical Learning Institute, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Successful completion of this continuing nursing education activity will be awarded 1.25 contact hour(s).

Faculty

Chair & Presenter

Jay B. Wish, MD
Indiana University Health
Indianapolis, Indiana

Presenters

Chilnille L. Milbrooks, MSN, FNP-C
IU Health Physicians
Indianapolis, Indiana

Daniel W. Coyne, MD
Washington University School of Medicine
St. Louis, Missouri

Disclosure and Conflict of Interest Policy

The Medical Learning Institute, Inc. (MLI) requires faculty, planners, staff, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they, and their spouse/life partners, may have as related to the content of this activity. These disclosures will be provided to learners prior to the start of the activity. All identified COI are thoroughly vetted and resolved according to MLI policy. MLI is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees for participating in or receiving credit for this accredited activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you upon completion. You will receive your certificate from email@email.peerviewpress.com. If you have questions regarding the receipt of your emailed certificate, please contact via email at info@PeerView.com.

Speaker(s):
Free

Welcome & Finding Joy in Our Work Lives

Preview Available

Welcome & Finding Joy in Our Work Lives

Aug 30, 2020 10:35am ‐ Aug 30, 2020 12:00pm

It is often the connections and relationships we develop that bring us joy in life, but we sometimes need to rediscover those sources of joy in order to deal with the stress we encounter in a busy professional life. Learn how to combat stress by reversing your thoughts and actions, making connections, finding joy, and laughing more.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will describe moments in their work nd home lives that bring them joy and describe ways to increase their experience of that joy.

Speaker(s):
  • Joy Baldridge, CPC, CSP, Certified Speaking Professional, Baldridge Seminars International
Members: $30.00
Standard: $40.00

Stop the Revolving Door: Home Dialysis Patient Retention Strategies

Preview Available

Stop the Revolving Door: Home Dialysis Patient Retention Strategies

Aug 30, 2020 12:15pm ‐ Aug 30, 2020 1:15pm

Explore the challenges of retaining patients on home therapy. Potential complications of long-term home dialysis, high-risk assessment, and strategies to maintain patients on home dialysis are discussed.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will describe challenges, concerns, and strategies that may assist in maintaining patients on home therapy.

Speaker(s):
  • Nupur Gupta, MD, Assistant Professor of Clinical Medicine, Indiana University
Members: $30.00
Standard: $40.00

Dyslipidemia Across the Kidney Disease Spectrum

Preview Available

Dyslipidemia Across the Kidney Disease Spectrum

Aug 30, 2020 12:15pm ‐ Aug 30, 2020 1:15pm

This session provides an overview of dyslipidemia, including laboratory findings and the association with various kidney diseases and disorders. Review treatment guidelines from organizations (American Heart Association, National Lipid Association, KDIGO) and practice applications for patients across the kidney disease spectrum.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

Speaker Disclosures:
• Leah Foster Smith – Owner, Interactive Nephrology

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will state an ability to develop or participate in a plan for care for patients with kidney disease and dyslipidemia that utilizes evidence-based guidelines.

Speaker(s):
  • Leah Foster Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF, Director of Advanced Practitioners, Metrolina Nephrology Associates
Members: $30.00
Standard: $40.00

General Session - COVID-19: Looking in the Rearview Mirror and Moving Forward

Preview Available

General Session - COVID-19: Looking in the Rearview Mirror and Moving Forward

Aug 30, 2020 1:45pm ‐ Aug 30, 2020 2:45pm

All of us have been affected personally and professionally by COVID-19. This presentation provides a brief look back at the impact of COVID-19 and focuses on how we apply lessons learned from this experience for nephrology nursing care now and in the future.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will outline a possible future and what changes our experiences of the COVID-19 pandemic may develop in nephrology nursing care.

Speaker(s):
Members: $30.00
Standard: $40.00

Understanding Basic Lab Values 101

Preview Available

Understanding Basic Lab Values 101

Aug 30, 2020 3:00pm ‐ Aug 30, 2020 4:00pm

This presentation reviews laboratory values that are key in diagnosing and assessing the progression of kidney disease, including anemia, electrolytes, nutrition, bone management, urine microscopy, and adequacy of dialysis.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will explain given lab values, what a patient will exhibit if lab values are not in balance, and the importance of assessing lab values to determine an effective treatment plan.

Speaker(s):
  • Deborah H. Brooks, MSN, RN, ANP-BC, CNN-NP, CNN, Nurse Practitioner, Medical University of South Carolina
Members: $30.00
Standard: $40.00

Vascular Access: Catch It Before It Fails

Preview Available

Vascular Access: Catch It Before It Fails

Aug 30, 2020 3:00pm ‐ Aug 30, 2020 4:00pm

A primary concern for nephrology nurses caring for dialysis patients is protecting and maintaining the patient’s access. Learn more about the signs of a failing access, procedures that facilitate identification of a problematic access, and the process for handling vascular access complications.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will state an increased ability to identify signs of a failing access as well as procedures that may assist in prolonging the life of that access.

Speaker(s):
  • Spencer Galt, MD, Staff Vascular Surgeon, Intermountain Health Care
Members: $30.00
Standard: $40.00

General Session - Innovations in Health Care and How They Influence Practice

Preview Available

General Session - Innovations in Health Care and How They Influence Practice

Aug 30, 2020 4:15pm ‐ Aug 30, 2020 5:15pm

Nephrology patient care is experiencing exciting innovation, including changes in technology, in how we care for patients, and in how patients access care. This session focuses on the need to delay kidney disease progression while also supporting treatment modality decisions. Apps and other technological resources are available to assist patients in managing their care. CVS Kidney Care is used as an example of a patient program that is using innovation to advance education and care for patients with kidney disease.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

Speaker Disclosures:
• Catherine Firanek – Employee, CVS Health

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will discuss innovations in changing patient education and care and the potential impact on their own professional practice.

Speaker(s):
Members: $30.00
Standard: $40.00

Transitional Care Units

Preview Available

Transitional Care Units

Aug 30, 2020 5:30pm ‐ Aug 30, 2020 6:30pm

What is a transitional care unit? How can this unit help achieve the 2025 goal for 50% of kidney disease patients to receive treatment at home? How do you start a transitional unit in your clinic? Discover the answers to these questions during this informative session.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

Speaker Disclosures:
• Melissa Herman – Employee, Fresenius Kidney Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will describe transitional units and the potential for these units to assist in meeting the 2023 goal for 50% of nephrology patients to receive care at home.

Speaker(s):
  • Melissa Herman, MBA, BSN, RN, Senior Director of Home Growth, Fresenius Medical Care
Members: $30.00
Standard: $40.00

What is Cannabis? Dive into the Weeds with CKD and Drug Interactions

Preview Available

What is Cannabis? Dive into the Weeds with CKD and Drug Interactions

Aug 30, 2020 5:30pm ‐ Aug 30, 2020 6:30pm

What is cannabis, and how is it being used in kidney care? Explore the differences between cannabis, marijuana, and hemp as well as the legalities associated with each substance. Learn about the dialyzability of these substances and the relationship to the disease process and common kidney disease treatments.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will critique the differences in cannabis, marijuana, and hemp in regard to legalities of use, dialyzability, and relation to chronic kidney disease and treatment.

Speaker(s):
Members: $30.00
Standard: $40.00